CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Bristol-Myers Squibb Company Company Snapshot
Bristol-Myers Squibb Company operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bristol-Myers Squibb Company with three other companies in this sector in UNITED STATES : Abbvie Inc (2020 sales of $45.80 billion of which 100% was pharmaceutical products), Merck & Co. , Inc. ($47.99 billion of which 90% was Merck Pharmaceutical), and Pfizer Inc. ($41.91 billion of which 26% was Oncology).

Sales Analysis. During the second quarter of 2021, sales at Bristol-Myers Squibb Company totalled $11.70 billion. This is an increase of 15.5% from the $10.13 billion in sales at the company during the second quarter of 2020. During the first two quarters of 2021, sales totalled $22.78 billion, which is 8.9% higher than through the first two quarters of 2020. During the previous 26 quarters, sales at Bristol-Myers Squibb Company have increased compared with the same quarter in the previous year. There appears to be at least some degree of seasonality in the sales at Bristol-Myers Squibb Company: during 8 of the previous 9 years, sales were highest during the fourth quarter. The exception to this was during 2012, when the first quarter was the best quarter, accounting for 30% of sales (during that same year, the fourth quarter accounted for 24% of sales). During the year ended December of 2020, sales at Bristol-Myers Squibb Company were $42.52 billion. This is an increase of 62.6% versus 2019, when the company's sales were $26.15 billion. This was the fifth consecutive year of sales increases at Bristol-Myers Squibb Company (and since 2015, sales have increased a total of 157%). Sales of Prioritized Brands-Revlimid saw an increase that was more than double the company's growth rate: sales were up 831.9% in 2020, from $1.30 billion to $12.11 billion. Not all segments of Bristol-Myers Squibb Company experienced an increase in sales in 2020: sales of Other Brands fell 21.4% to $1.32 billion. Bristol-Myers Squibb Company also experienced decreases in sales in Prioritized Brands-Opdivo (down 2.9% to $6.99 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Bristol-Myers Squibb Company
  Stock Performance Chart for Bristol-Myers Squibb Company
 
  Stock Data: Recent Stock Performance:
  Current Price (9/24/2021): 60.23
(Figures in U.S. Dollars)
1 Week -1.8%   13 Weeks -9.6%  
4 Weeks -9.8%   52 Weeks 1.2%  
 
Bristol-Myers Squibb Company Key Data:
  Ticker: BMY Country: United States
  Exchanges: NYSE FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 42,518,000,000
(Year Ending Jan 2021).
Employees: 30,250
  Currency: U.S. Dollars Market Cap: 133,831,060,000
  Fiscal Yr Ends: December Shares Outstanding: 2,222,000,000
  Share Type: Common Closely Held Shares: 1,505,722
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.